Christopher L. Gaenzle, EVP, CAO & General Counsel at PRA Health Sciences, Inc. (PRAH), sold 57,030 shares at $166.48 ($9.5M) on 2021-06-16, disclosed to the SEC on 2021-06-17.
Open-market sale of $9.5M PRAH by EVP, CAO & General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $168.27 | 14,386 | $2.4M | 25.4% |
| 2 | $168.27 | 14,386 | $2.4M | 25.4% |
| 3 | $168.83 | 202 | $34K | 0.4% |
| 4 | $166.48 | 13,778 | $2.3M | 24.0% |
| 5 | $166.48 | 13,778 | $2.3M | 24.0% |
| 6 | $167.49 | 500 |
| $84K |
| 0.9% |
| Total | $167.40 avg | 57,030 | $9.5M | 100% |
| Filing → |
| PRAH | SELL | 2021-01-11 | $816K | — | Filing → |
| PRAH | SELL | 2020-08-17 | $281K | — | Filing → |
| SYNH | SELL | 2018-01-23 | $60K | — | Filing → |